Arnicare Bruise Tablets

Manufacturer
Boiron | Boiron Inc.
Effective date
2025-07-15
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 02:34:28

Label at a glance#

ProductArnicare Bruise
Active ingredientARNICA MONTANA
Label structure12 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredient** (in each tablet)

Arnica montana 9C HPUS (2.5 mg)

The letters "HPUS" indicate that the component in this product is officially monographed in the Homeopathic Pharmacopoeia of the United States.

OTC - PURPOSE SECTION

Purpose*

Arnica montana 9C HPUS (2.5 mg) ... Reduces minor pain, swelling & discoloration from bruises

INDICATIONS & USAGE SECTION

Uses*

reduces symptoms of bruising such as:

  • minor pain
  • swelling
  • discoloration

OTC - ASK DOCTOR SECTION

Ask a doctor before use if bruising limits the range of motion of your eyes, limbs, head, pain is severe, or bruising is frequent.

OTC - STOP USE SECTION

Stop use and ask a doctor if

  • adult's symptoms get worse or last more than 7 days
  • child's symptoms get worse or last more than 5 days
  • new symptoms occur, or if redness or swelling is present. These could be signs of a serious condition.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health profession before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Directions

Adults and children 6 years of age and older - As soon as bruising occurs, dissolve 2 tablets under the tongue and repeat 3 times a day. Decrease frequency with improvement.

Children 2 to 6 years of age - Dissolve 2 tablets in 1 tablespoon of water for easier intake. Follow directions above.

Children under 2 years of age - Ask a doctor.

SPL UNCLASSIFIED SECTION

  • do not use if glued carton end flaps are open or if the blister seal is broken
  • store below 86° F (30° C)

60 meltaway tablets

Bruise relief*

Discoloration, Pain, Swelling*

No Known Drug Interactions

*CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE. NOT FDA EVALUATED.

**C,K,CK, and X are homeopathic dilutions: see BoironUSA.com/info for details.

INACTIVE INGREDIENT SECTION

croscarmellose sodium, lactose, magnesium stearate

OTC - QUESTIONS SECTION

Arnicare.com

BoironUSA.com

Info@Boiron.com

1-800-BOIRON-1

(1-800-264-7661)

Made in France

Distributed by Boiron Inc.

Newtown Square, PA 19073

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

labellabel

ETU.1GYCETU.1GYC

labellabel

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0220-9083-04Arnicare Bruise60 in 1 BLISTER PACKTABLET604

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0220-90830220-9083-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Arnicare BruiseARNICA MONTANABoirond5e1a96c-4a19-c58c-e053-2a95a90aca9e2025-07-15Exact identifier
ndc (package): 0220-9083-04
ndc (product): 0220-9083
ndc11 (package): 00220908304
spl id: 39fc5ac1-2ea9-12b9-e063-6394a90af459
spl set id: d5e1a96c-4a19-c58c-e053-2a95a90aca9e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.